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letters to the editor

5-YEAR SURVIVAL OF A PATIENT
WITH MALIGNANT THYMOMA
WITH SUPERIOR VENA CAVAL
SYNDROME
Dear Sir,
Thymoma is an uncommon neoplasm that is derived from the
epithelial cells of the thymus. It is well known for its
association with myasthenia gravis (MG) or other
autoimmune disease, histologic variability, and heterogeneity
of malignant behaviour.! Surgery remains the mainstay of
treatment while radiation and chemotherapy also have been
applied widely as adjuvant and paliiative procedures. Most
malignant thymomas are slow-growing tumors which
uncommonly metastasize hematogenously and have a
tendency to recur locally.
A 41-year-old man presented to the Emergency Room with a
4-month history of cough, shortness of breath and low grade
intermittent fever with no other past or present medical
problems. On physical examination, he had extensive facial
swelling and engorged neck veins. The rest of the physical
examination was unremarkable. Chest X-ray showed
Widening of mediastinum. CT-scan of the chest was
performed which showed a lobulated soft tissue mass (6x4cm)
in the anterior mediastinum along with calcification in its
peripheral margins. Superior Vena Caval (SVC) thrombosis
Was also identified with collateral development. VATS (video
assisted thoracoscopic surgery) was performed to get the
biopsy and the histopathology report showed changes
consistent with malignant thymoma. Elective thymectomy
Was performed. The anterior mediastinal mass was found to
he hard and encasing the SVC which was thrombosed. Further
dissection revealed that the innominate artery;. right carotid
and right subclavian arteries were encased in the thymoma.
'fhe tumor was projecting deep posterior to the pulmonary
artery and around the aorta and had completely invaded the
left phrenic nerve and left innominate vein. Pulmonary
extension of the tumor was evident by involvement of the
right and left upper lubes. The entire tumor along with
portions of both upper lobes was removed. Since there was
lrtvolvement of the left phrenic nerve as well, pericardium and
the left phrenic nerve were taken along with the tumor. The
tumor was shaved off the thrombosed SVC.
The patient received postoperative radiotherapy and has been
followed by the oncology service routinely since surgery. The
facial swelling subsided completely 3 months after surgery.
On a 5 years follow-up, the patient has shown no recurrence of
his tumor on CAT scan and is total! y asymptomatic.
alignant thymomas are rare, slow-growing tumors and
tients commonly present with cough, chest pain, phrenic
nerve palsy or SVC syndrome, or less frequently with fever,
r~ght sweats and weight loss. CT scanning is usually accurate
In predicting tumor size, location and invasion into vessels,
'pericardium and lung.
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Even though invasiveness of the tumor remains the single
most consistent factor in predicting outcome, several factors
adversely affect the prognosis of malignant thymoma as well
including' intrathoracic or extrathoracic metastasis, tumor
size > lOcm, extent of surgical re..c;;ection, tracheal or vascular
compromise, age < 30 years and epithelial/ mixed histologies.
Initially, the presence of an associated paraneoplastic
syndrome or myasthenia gravis was regarded as a negative
prognostic factor,2,.3A however, now these are not associated
with inferior outcome any more, possibly because of earlier
detection.2
Surgical resection remains the main mode of therapy, with an
enbloc removal for invasive tumors in patients who can
tolerate surgery and do not have extensive metastatic disease.
The extent and completeness of surgical resection determines
outcume.4 In patients with extensive metastasis and unstable
medical condition, debulking or biopsy may be the only
option. In such cases, postoperative radiotherapy has been
shown to increase survival rates. 2
Thymomas appropriately treated by complete surgical
resection, result in a 960% 10-year surviva.l The stage of the
disease has an important impact upon survival outcomes.
Malignant thymoma often involves the phrenic nerves and
there is a probabililty of impaired respiratory function if the
nerve is divided. Preoperative pulmonary function tests
should be performed in all patients so that any respiratory
compromise following surgical resection of the phrenic nerve
can be estimated. In patients with completely resected stage II
or III thymomas, adjuvant radiotherapy reduces the rate of
local recurrence from approximately 28 to 5%.4
Thymomas are chemosensitive malignancies.s It is
recommended that patients with unresectable disease should
be given aggressive management with trimodality therapy.
Cisplatin-containing regimens are by far the most active with
overall response rates of 70-80%, of which half are complete.
The most commonly used regimens are ADOC:, PAC and Ep
(etoposide and cisplatin). For recurrent disease, ADOC or PAC
regimen can be used and in cases of patients not being able to
tolerate cisplatin, carbuplatin can be substituted. Currently,
carboplatin and paclitaxel combination is being shtdied in
clinical research.
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ERRATA

1. The name of co-author, Ali S.M. Akhtar has been misprinted as
S.M. Akhtar in the article "NEONATAL COMPLICATIONS IN
INFANTS BORN TO DIABETIC MOTHERS" published in
JCPSP 2006, Vol. 16 (3): 212-15. The name may be corrected and
read as A.S.M. Akhtar.
2. A discrepancy has occurred in the authorship of the article:
"TRACHEAL INJURY DUE TQ BLUNT CHEST TRAUMA:
A RARE SURGICAL EMERGENCY" by Usman Ahmad,
Muhammad A. Javed and Saulat H. Fatimi, published in
JCPSP 2006,Vol. 16 (6): 422-23. The name of fourth co-author,
Fahad Shuja, was inadvertently omitted and could not be printed.
His name may be included in the above article and the authors'
list should read as: Usman Ahmad, Muhammad A. Javed, Saulat
H. Fatimi and Fahad Shuja.
3. Due to a typographic error the 'u' of edu was omitted from the
E-mail address of correspondence author of the article titled
"CORD BLOOD LEPTIN LEVELS IN PAKISTANI NEWBORNS:
RELATIONSHIP WITH BIRTH WEIGHT, LENGTH AND
OCCIPITOFRONTAL CIRCUMFERENCE" published in JCPSP
2006, Vol. 16 (6): 393-95. The E-mail address should read as
ghulam.lakho@aku.edu.
Editor
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